{"lastClose": 1.4700000286102295, "len": 468, "date": "2023-02-24", "alpha_1": -0.5367366329507204, "beta_1": 2.497571937116569, "drawup_1": 0.6999999674883763, "natr_1": 31.544676969605067, "sup_1": -0.328798190354363, "res_1": 0.532879786597535, "bullPattern_1": [], "bearPattern_1": ["CLOSINGMARUBOZU", "LONGLINE"], "rsi_1": 48.78892853456974, "adx_1": 24.13657004238328, "drawdown_1": -0.6811279856754398, "stratHoldSharpe_1": -0.68341683782104, "stratHoldAlpha_1": 250.4126004397646, "stratHoldDrawdown_1": -0.6130151871078958, "alpha_3mo": -0.012705698343949301, "beta_3mo": 2.610767128107059, "drawup_3mo": 0.44078952940877514, "natr_3mo": 31.544676969605067, "sup_3mo": -0.14058959453758718, "res_3mo": 0.018140571915881386, "bullPattern_3mo": [], "bearPattern_3mo": ["CLOSINGMARUBOZU", "LONGLINE"], "rsi_3mo": 21.359220042350557, "adx_3mo": 66.27379913538816, "drawdown_3mo": -0.3287671277616546, "stratHoldSharpe_3mo": -0.7889625225683695, "stratHoldAlpha_3mo": 250.40584845867673, "stratHoldDrawdown_3mo": -0.3005565907024288, "Name": "Ginkgo Bioworks Holdings Inc. Class A", "Market Cap": 3039090646, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2021.0, "Country": "United States", "Sector": "Health Care", "alpha%_1": 0.06552319089739253, "beta%_1": 0.998630659322246, "drawup%_1": 0.6546339050505579, "natr%_1": 1.0, "drawdown%_1": 0.060764068831164905, "stratHoldSharpe%_1": 0.1284249166692612, "stratHoldAlpha%_1": 0.007452212484970753, "stratHoldDrawdown%_1": 0.06838310195873257, "alpha%_3mo": 0.2564296562757053, "beta%_3mo": 0.9980065459540536, "drawup%_3mo": 0.8623964962326497, "natr%_3mo": 1.0, "drawdown%_3mo": 0.017603398833700972, "stratHoldSharpe%_3mo": 0.18183790285055307, "stratHoldAlpha%_3mo": 0.06724299626839261, "stratHoldDrawdown%_3mo": 0.017320355306978195}